Connection

Perry Molinoff to Guanosine Triphosphate

This is a "connection" page, showing publications Perry Molinoff has written about Guanosine Triphosphate.
Connection Strength

0.289
  1. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21.
    View in: PubMed
    Score: 0.041
  2. Effects of ethanol in vitro on the beta adrenergic receptor-coupled adenylate cyclase system. J Pharmacol Exp Ther. 1988 Sep; 246(3):1040-7.
    View in: PubMed
    Score: 0.019
  3. Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci. 1988 May; 29(5):687-94.
    View in: PubMed
    Score: 0.019
  4. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland. J Pharmacol Exp Ther. 1987 Sep; 242(3):950-6.
    View in: PubMed
    Score: 0.018
  5. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):165-72.
    View in: PubMed
    Score: 0.016
  6. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther. 1985 Dec; 235(3):657-64.
    View in: PubMed
    Score: 0.016
  7. Interactions of agonists with beta-adrenergic receptors on S49 lymphoma cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:13-27.
    View in: PubMed
    Score: 0.015
  8. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.015
  9. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
    View in: PubMed
    Score: 0.014
  10. A comprehensive method for the quantitative determination of dopamine receptor subtypes. Ann N Y Acad Sci. 1984; 430:77-90.
    View in: PubMed
    Score: 0.014
  11. Multiple sites of action of ethanol on adenylate cyclase. J Pharmacol Exp Ther. 1983 Dec; 227(3):551-6.
    View in: PubMed
    Score: 0.014
  12. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Mol Pharmacol. 1983 Mar; 23(2):303-9.
    View in: PubMed
    Score: 0.013
  13. Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. J Pharmacol Exp Ther. 1983 Jan; 224(1):1-6.
    View in: PubMed
    Score: 0.013
  14. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67.
    View in: PubMed
    Score: 0.011
  15. Classification and quantitation of beta-adrenergic receptor subtypes. Biochem Pharmacol. 1980 May 15; 29(10):1317-23.
    View in: PubMed
    Score: 0.011
  16. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells. J Cyclic Nucleotide Res. 1980; 6(6):421-35.
    View in: PubMed
    Score: 0.011
  17. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther. 1978 Nov; 207(2):446-57.
    View in: PubMed
    Score: 0.010
  18. Expression of the human 5-hydroxytryptamine1A receptor in Sf9 cells. Reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits. J Biol Chem. 1995 Aug 04; 270(31):18691-9.
    View in: PubMed
    Score: 0.008
  19. Skeletal muscle beta-receptors and isoproterenol-stimulated vasodilation in canine heart failure. J Appl Physiol (1985). 1989 Nov; 67(5):2026-31.
    View in: PubMed
    Score: 0.005
  20. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol. 1989 Aug; 257(2 Pt 1):E277-83.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.